Abstract: Novel proteins from Streptococcus pneumoniae are described, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.
Type:
Application
Filed:
June 7, 2006
Publication date:
November 23, 2006
Applicant:
Microbial Technics Limited
Inventors:
Richard Le Page, Jeremy Wells, Sean Hanniffy, Philip Hansbro
Abstract: Novel protein antigens from Group B Streptococcus are described, together with nucleic acid sequences encoding them. Their use in vaccines and screening methods is also described.
Type:
Grant
Filed:
January 26, 2001
Date of Patent:
August 29, 2006
Assignee:
Microbial Technics Limited
Inventors:
Richard William Falla Le Page, Jeremy Mark Wells, Sean Bosco Hanniffy
Abstract: Protein antigens from Group B Streptococcus are described, together with nucleic acid sequences encoding them. Their use in vaccines and screening methods are described.
Type:
Application
Filed:
May 6, 2005
Publication date:
April 13, 2006
Applicant:
Microbial Technics Limited
Inventors:
Richard William Le Page, Jeremy Wells, Sean Hanniffy
Abstract: Novel protein antigens from Streptococcus pneumoniae are disclosed, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.
Type:
Application
Filed:
June 23, 2004
Publication date:
December 15, 2005
Applicant:
Microbial Technics Limited
Inventors:
Christophe Francois Gilbert, Philip Hansbro
Abstract: Novel protein antigens from Streptococcus pneumoniae are disclosed, together with nucliec acid sequences encoding them. Their use in vaccines and in screening methods is also described.
Type:
Grant
Filed:
January 26, 2001
Date of Patent:
August 30, 2005
Assignee:
Microbial Technics Limited
Inventors:
Christophe Francois Guy Gilbert, Philip Michael Hansbro
Abstract: Biologically active polypeptides and/or antigens are delivered by administering to a subject a non-invasive or non-pathogenic bacterium which expresses one or more antigens or polypeptides. The non-invasive or non-pathogenic bacterium can be included in delivery systems or pharmaceutical formulations.
Type:
Grant
Filed:
April 16, 1998
Date of Patent:
August 12, 2003
Assignees:
Vlaams Interuniversitair Instituut voor Biotechnologie, Microbial Technics Limited
Inventors:
Lothar Steidler, Erik Remaut, Jeremy Mark Wells, Richard William Falla Le Page